TCP
AGN

TAMRO Capital Partners’s Allergan Inc AGN Stock Holding History

TAMRO Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,546
Closed -$1.18M – 111
2014
Q4 		$1.18M Sell
5,546
-272
-5% -$54.1K 0.08% 97
2014
Q3 		$1.04M Sell
5,818
-2,697
-32% -$448K 0.07% 109
2014
Q2 		$1.44M Sell
8,515
-10,389
-55% -$1.62M 0.07% 102
2014
Q1 		$2.35M Sell
18,904
-1,046
-5% -$127K 0.1% 66
2013
Q4 		$2.22M Sell
19,950
-3,513
-15% -$336K 0.09% 83
2013
Q3 		$2.12M Sell
23,463
-981
-4% -$88.1K 0.09% 87
2013
Q2 		$2.06M Buy
+24,444
New +$2.54M 0.09% 86

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

TAMRO Capital Partners's AGN Position: Q1 2015 in Review

TAMRO Capital Partners sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 5,546 shares — an estimated $1.18M sold.

TAMRO Capital Partners first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $2.35M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • TAMRO Capital Partners reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • TAMRO Capital Partners sold 5,546 Allergan Inc shares in Q1 2015, an estimated $1.18M.
  • TAMRO Capital Partners first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • TAMRO Capital Partners's Allergan Inc position peaked at $2.35M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on TAMRO Capital Partners's 13F filing for Q1 2015, filed 7 May 2015.